Matches in Wikidata for { <http://www.wikidata.org/entity/Q64183675> ?p ?o ?g. }
Showing items 1 to 34 of
34
with 100 items per page.
- Q64183675 description "clinical trial" @default.
- Q64183675 description "ensayu clínicu" @default.
- Q64183675 description "klinisch onderzoek" @default.
- Q64183675 description "клінічне випробування" @default.
- Q64183675 name "Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus Uncontrolled on Other Kinds of Insulin" @default.
- Q64183675 type Item @default.
- Q64183675 label "Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus Uncontrolled on Other Kinds of Insulin" @default.
- Q64183675 prefLabel "Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus Uncontrolled on Other Kinds of Insulin" @default.
- Q64183675 P1050 Q64183675-74E184B0-FDD0-4A0A-BA03-612690C5C6F8 @default.
- Q64183675 P1132 Q64183675-0A896AB9-9963-4416-8E24-9CCA16962DF1 @default.
- Q64183675 P1476 Q64183675-D83316FC-0B2D-4456-97C1-4F71475CDEFD @default.
- Q64183675 P17 Q64183675-5AFD3DF8-30CA-4DA2-9984-88C0F21C7CC5 @default.
- Q64183675 P17 Q64183675-68DF7790-E6F7-4EC2-9A92-DC022024D3CD @default.
- Q64183675 P1813 Q64183675-ACF05351-598F-446F-A829-F0C041840B4E @default.
- Q64183675 P2899 Q64183675-5AE12297-0EF4-4B91-AC60-C1F98EB8FDCE @default.
- Q64183675 P3098 Q64183675-9A462AE1-010D-426A-9F50-447B17C1BA50 @default.
- Q64183675 P31 Q64183675-274ECC61-BB37-46F9-8D58-A51DAC98F3E1 @default.
- Q64183675 P580 Q64183675-77ACB1DE-D8DA-4687-80D7-85B1FFB338E0 @default.
- Q64183675 P582 Q64183675-13707162-3EB8-414E-AE62-5D8632DDDF9E @default.
- Q64183675 P6099 Q64183675-D8BFF80D-DC88-49FB-8C41-1A7B8B0EAD86 @default.
- Q64183675 P8363 Q64183675-BEC13CB0-EEBF-4CB7-A79B-2478B733ABB8 @default.
- Q64183675 P1050 Q12206 @default.
- Q64183675 P1132 "+430" @default.
- Q64183675 P1476 "A Multicenter, Multinational, Prospective, Interventional, Single-arm, Phase IV Study Evaluating the Clinical Efficacy and Safety of 26 Weeks of Treatment With Insulin Glargine 300 U/mL (Gla-300) in Patients With Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin" @default.
- Q64183675 P17 Q258 @default.
- Q64183675 P17 Q833 @default.
- Q64183675 P1813 "ARTEMIS-DM" @default.
- Q64183675 P2899 "+18" @default.
- Q64183675 P3098 "NCT03760991" @default.
- Q64183675 P31 Q30612 @default.
- Q64183675 P580 "2018-12-18T00:00:00Z" @default.
- Q64183675 P582 "2020-07-01T00:00:00Z" @default.
- Q64183675 P6099 Q42825046 @default.
- Q64183675 P8363 Q78089383 @default.